B-Secur and Galen Data Unite to Revolutionize Cardiac Health Monitoring for Medical Device Manufacturers

B-Secur and Galen Data have recently partnered to enhance cardiac health monitoring for medical device manufacturers. The collaboration brings together two leading technology companies to provide a comprehensive solution that combines advanced biosensing technology with secure medical device cloud platform, data analysis and seamless integration with Electronic Health Records. Through this partnership, medical device companies can reduce software development timelines, costs, and operational risks, ultimately delivering an efficient and comprehensive solution for cardiac health monitoring.

Galen Data is recognized for its trusted software platform for medical device-to-cloud connectivity and data analysis, while B-Secur is known for its advanced biosensing technology. With the global cardiac monitoring market projected to reach $16 billion by 2030, this partnership signifies a significant advancement in cardiac care technology. The goal of this collaboration is to drive innovation and provide a reliable and comprehensive platform that revolutionizes patient monitoring and supports the future of cardiac care.

The partnership between B-Secur and Galen Data brings together two leading technology companies to provide unparalleled insights and capabilities to cardiac device manufacturers. Alex Condon, COO of Galen Data, emphasized the shared vision of improving cardiac care through innovative technology with Brian Pitstick, CCO of B-Secur. By combining Galen Data’s secure medical device cloud platform with B-Secur’s HeartKey® Technology, the partnership provides real-time monitoring, easy cloud integration, robust data management, and seamless integration with Electronic Health Records. This integration allows medical device companies to improve their operations while reducing costs. Ultimately, this collaboration delivers an efficient and comprehensive solution that supports the future of cardiac care.